ArticleAnnals of hematology2024

The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.

Olga Mulas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.